Plasma levels of IL-6 and TNF-α in patients with esophageal cancer

Turkish Journal of Medical Sciences

Volumn 42, Issue 5, 2012, Pages 762-767

  Aydin, Yener ^a   Kaplan, Ibrahim ^a   Bilen, Yusuf ^a   Bulut, Çaǧlar ^a   Genç, Fatma ^b   Türkyilmaz, Atila ^a   Eroǧlu, Atila ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Esophageal cancer; IL 6; TNF a

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISTANT METASTASIS; DYSPHAGIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MALE; WEIGHT REDUCTION;

EID: 84864079284     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Türkyi{dotless}lmaz A, Eroǧlu A, Aydi{dotless}n Y, Yi{dotless}lmaz Ö, Karaoǧlanoǧlu N. Survival in esophageal cancer patients with hematogenous distant organ metastases. Turk J Med Sci 2009; 39: 415-21.
2. Millikan KW, Silverstein J, Hart V, Blair K, Bines S, Roberts J et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 1995; 130: 617-24.
3. Türkyi{dotless}lmaz A, Eroǧlu A, Aydi{dotless}n Y, Yi{dotless}lmaz Ö, Karaoǧlanoǧlu N. The relationship of serum CEA and CA 19-9 levels to liver metastasis and pancreatic invasion in esophageal cancer. Turk J Med Sci 2009; 39: 895-9.
4. Karadaǧ R, Koca C, Totan Y, Yaǧci{dotless} R, Aydi{dotless}n M, Karadaǧ AS et al. Comparison of serum levels of IL-6, IL-8, TNF-α, C reactive protein and heat shock protein 70 in patients with active or inactive Behçet's disease. Turk J Med Sci 2010; 40: 57-62.
5. Gülseken KH, Köksal İT, Özdem S, Saka O. Prediction of prostate cancer using decision tree algorithm. Turk J Med Sci 2010; 40: 681-6.
6. Sacu D, Bildik A. Levels of interleukin 6 and tumor necrosis factor-α in serum from fi brosarcoma induced rats. Kafk as Univ Vet Med Journal 2009; 15: 681-6.
7. Koszałka P, Szmit E, Myśliwski A, Bigda J. Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters. Arch Immunol Ther Exp 2007; 55: 267-79.
8. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 2004; 101: 2727-36.
9. Kemik Ö, Sarbay Kemik A, Dülger AC, Hasi{dotless}rci{dotless} İ, Daştan E, Barti{dotless}n MK et al. The serum levels of interleukin-6 in colon cancer patients with liver metastasis. Van Med J 2010; 17: 42-5.
10. Ben-Baruch A. Host microenvironment in breast cancer development: infl ammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor microenvironment interactions. Breast Cancer Res 2003; 5: 31-6.
11. Van der Zee AGJ, de Cuyper EMJ, Limburg PC, de Bruijn HWA, Hollema H, Bijzet J et al. Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts. Cancer 1995; 75: 1004-9.
12. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990; 50: 6959-65.
13. Obata NH, Tamakoshi K, Shibata K, Kikkawa F, Tomoda Y. Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human carcinoma. Anticancer Res 1997; 17: 337-42.
14. Nash MA, Fernandina G, Gordinier M, Loercher A, Freedman RS. The role of cytokines in both the normal and malignant ovary. Endocr Rel Cancer 1999; 6: 93-107.
15. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T et al. Study of interleukin-6 in the spread of colorectal cancer: the diagnostic signifi cance of IL-6. Acta Med Okayama 2006; 60: 325-30.
16. Knüpfer H, Preiss R. Serum interleukin-6 levels in colorectal cancer patients--a summary of published results. Int J Colorectal Dis 2010; 25: 135-40.
17. De Vita F, Romano C, Orditura M, Galizia G, Martinelli E, Lieto E et al. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res 2001; 21: 45-52.
18. Seymour JF, Talpaz M, Cabanillas F, Wetzler M, Kurzrock R. Serum interleukin-6 levels correlate with prognosis in diff use large cell lymphoma. J Clin Oncol 1995; 13: 575-82.
19. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92: 1684-8.
20. Okada S, Okusaka T, Ishii H, Kyogoku A, Yoshimori M, Kajimura N et al. Elevated serum interleukin-6 levels in patients with pancreatic cancer. Jpn J Clin Oncol 1998; 28: 12-5.
21. Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219: 325-31.
22. Nakagoe T, Tsuji T, Sawai T, Tanaka K, Hidaka S, Shibasaki S et al. Increased serum levels of interleukin-6 in malnourished patients with colorectal cancer. Cancer Letters 2003; 202: 109-15.
23. Konukoǧlu D, Turhan SM. Molecular basis of angiogenesis mechanisms and tumor angiogenesis. Cerrahpaşa J Med 2005; 36: 42-8.
24. Kelle İ. Biotoxins in cancer therapy. Dicle Ti{dotless}p Dergisi 2007; 34: 226-32.
25. Şenel S, Ki{dotless}li{dotless}çkap S. Anti-tumor necrosis factor therapy and cancer. Cumhuriyet Med J 2010; 32: 132-6.
26. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R et al. The infl ammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 2007; 67: 585-92.
27. Kulbe H, Hagermann T, Szlosarek PW, Balkwill FR, Wilson JL. The infl ammatory cytokine TNF-α upregulates chemokine receptor expression on ovarian cancer cells. Cancer Res 2005; 65: 10355-62.
28. Shouda T, Hiraoka K, Komiya S, Hamada T, Zenmyo M, Iwasaki H et al. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. Cancer Lett 2004; 231: 176-84.
29. Grimm EA, Smid CM, Lee JJ, Tseng CH, Eton O, Buzaid CA. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy. Clin Cancer Res 2000; 6: 3895-3903.
30. Giri D, Ozen M, Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 2001; 159: 2159-65.
31. Enewold L, Mechanic LE, Bowman ED, Zheng YL, Yu Z, Trivers G et al. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2009; 18: 215-22.